Omnigene Oral Dna/Rna Tender in USA - 22199435

Procurement Summary

Country: USA

Summary: Omnigene Oral Dna/Rna

Deadline: 16 Apr 2018

Posting Date: 06 Apr 2018

Other Information

Notice Type: Tender

TOT Ref.No.: 22199435

Document Ref. No.: NICHD-18-042

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in far 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is nichd-18-042 and is issued as a request for quotation (rfq). The solicitation/contract will include all applicable provisions and clauses in effect through federal acquisition circular 2005-97. The north american industry classification (naics) code is 325414 and the business size standard is 1250 employees. However, this solicitation is not set aside for small business. This acquisition is being conducted using simplified acquisition procedures in accordance with far part 13. Eunice kennedy shriver national institute of child health and human development (nichd) intend to procure on a sole source basis with dna genotek inc. To provide the following:
1. Item# mo-3: mailing accessory - bio specimen bag - qty 4, 000 ea
2. Item# om-505: omnigene oral for microbial dna and rna - qty 1, 000 ea
3. Item# om-ac1: paper toilet accessory - qty 1, 000 ea
4. Item# omr-110: omnigene oral for gums and plaque - qty 1, 000 ea
5. Item# omr-200: omnigene gut sample collection kit-ruo - qty 1, 000 ea
6. Item# re-100: oragene, rna vial format - qty 1, 000 ea
the perinatology research branch s new prospective cohort biomarker study is proposed to examine the natural history of normal pregnancy and the most frequent pregnancy complications. These obstetrical disorders result in the majority of perinatal morbidity and mortality, which impose a substantial social and financial cost to society. This protocol aims to understand and predict those diseases that cause women and children the greatest morbidity and mortality. The reduction in infant mortality and preterm birth is an expressly high research priority for the nichd. The goal of this study is to develop predictive mode...

Documents

 Tender Notice